Table 1 Clinical and laboratory characteristics.
From: Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus
| Â | T1DM | P values (a) | T2DM | Controls | P values (b) |
|---|---|---|---|---|---|
Gender (males/females) | 58/62 | 0,602 | 156/150 | 93/87 | 0,198 |
Mean age (years) | 40 ± 12 | 0,022 | 57 ± 15 | 39 ± 9 | 0,043 |
Duration of DM (years) | 18 ± 9 | 0,853 | 17 ± 8 | 0 | - |
BMI (kg/m2) | 22 ± 4 | 0,03 | 30 ± 5 | 21 ± 5 | 0,027 |
Systolic BP (mmHg) | 120 ± 10 | 0,748 | 125 ± 25 | 120 ± 20 | 0,676 |
Diastolic BP (mmHg) | 60 ± 20 | 0,521 | 70 ± 30 | 70 ± 15 | 0,621 |
Microvascular complications(n) | 40 | 0,048 | 159 | 0 | - |
Macrovascular complications(n) | 14 | 0,016 | 52 | 0 | - |
FPG (mmol/l) | 6,60 ± 1,35 | 0,058 | 7,82 ± 2,29 | 4,95 ± 0,76 | 0,009 |
HbA1c (%) | 6,1 ± 1,9 | 0,321 | 6,7 ± 1,8 | 0 | - |
GFR (MDRD) (ml/s/1,73 m 2) | 1,23 ± 0,35 | 0,179 | 1,09 ± 0,28 | 1,35 ± 0,22 | 0,041 |
Total cholesterol (mmol/l) | 4,8 ± 0,5 | 0,042 | 5,3 ± 0,7 | 4,8 ± 0,3 | 0,205 |
HDL-C (mmol/l) | 1,55 ± 0,35 | 0,216 | 1,31 ± 0,32 | 1,75 ± 0,66 | 0,325 |
LDL-C (mmol/l) | 3,22 ± 0,53 | 0,116 | 3,57 ± 0,81 | 3,10 ± 0,74 | 0,234 |
Triglycerides (mmol/l) | 1,31 ± 0,30 | 0,031 | 1,99 ± 0,79 | 1,23 ± 0,48 | 0,038 |